A. Vakalopoulos

发表

Prediction of a potentially effective dose in humans for BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein (CETP) by allometric species scaling and combined pharmacodynamic and physiologically-based pharmacokinetic modelling.

Stefan Willmann, Carsten Schmeck, F. Hafner, 2012, British journal of clinical pharmacology.

Versatile 8-oxabicyclo[3.2.1]oct-6-en-3-one: stereoselective methodology for generating C-glycosides, delta-valerolactones, and polyacetate segments.

A. Vakalopoulos, H. Hoffmann, 2001, Organic letters.

Dibenzodioxocinones--a new class of CETP inhibitors.

F. Hafner, V. Li, A. Vakalopoulos, 2005, Bioorganic & medicinal chemistry letters.

Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy

R. Seifert, A. Vakalopoulos, L. Dietz, 2021, International journal of molecular sciences.

Neladenoson Bialanate Hydrochloride: A Prodrug of a Partial Adenosine A1 Receptor Agonist for the Chronic Treatment of Heart Diseases

Nicole Diedrichs, A. Vakalopoulos, Frank Süssmeier, 2017, ChemMedChem.

Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity.

Astrid A. Ortiz, Andrea Mcclure, D. Bierer, 2007, Journal of medicinal chemistry.

Chelation, activation, and proximity effects in the deprotection of dithianes with ZnBr(2): applications in the polyketide field.

A. Vakalopoulos, H. Hoffmann, 2001, Organic letters.

New copper-mediated O-arylations of phenols with arylstannanes

A. Vakalopoulos, Xanthoula Kavazoudi, J. Schoof, 2006 .

Investigations Into Chemically Stabilized Four-Letter DNA for DNA-Encoded Chemistry

S. Kast, A. Vakalopoulos, Marco Potowski, 2022, Frontiers in Chemistry.

Asymmetric synthesis of the northern half C1-C16 of the bryostatins.

T. Lampe, A. Vakalopoulos, H. Hoffmann, 2001, Organic letters.

Structural and Stereochemical Diversity from (±)-2,2-Dimethyl-8-oxabicyclo[3.2.1]oct-6-en-3-one − Application to the Synthesis of Polyketide Segments of Natural Products

A. Vakalopoulos, R. Smits, H. Hoffmann, 2002 .

Soluble guanylate cyclase stimulators and their potential use: a patent review

J. Stasch, M. Follmann, A. Vakalopoulos, 2021, Expert opinion on therapeutic patents.

Novel Deprotection of SEM Ethers: A Very Mild and Selective Method Using Magnesium Bromide.

A. Vakalopoulos, H. Hoffmann, 2000 .

New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension.

H. Trübel, J. Stasch, M. Follmann, 2023, Journal of medicinal chemistry.

Chemically Stabilized DNA Barcodes for DNA‐Encoded Chemistry

S. Kast, A. Vakalopoulos, Marco Potowski, 2021, Angewandte Chemie.

Novel tetrahydrochinoline derived CETP inhibitors.

Heike Gielen-Haertwig, Olaf Weber, H. Bischoff, 2010, Bioorganic & medicinal chemistry letters.

Chromanol derivatives--a novel class of CETP inhibitors.

H. Paulsen, Olaf Weber, H. Bischoff, 2011, Bioorganic & medicinal chemistry letters.